Hypermarcas (OTCMKTS:HYPMY) Shares Gap Down – Here’s Why

Shares of Hypermarcas (OTCMKTS:HYPMY) gapped down before the market opened on Monday . The stock had previously closed at $4.17, but opened at $3.97. Hypermarcas shares last traded at $3.97, with a volume of 155 shares traded.

Analysts Set New Price Targets

Separately, Zacks Research raised Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy”.

Hypermarcas Stock Down 0.4%

The business’s 50-day simple moving average is $4.32 and its two-hundred day simple moving average is $4.40. The firm has a market capitalization of $2.84 billion, a price-to-earnings ratio of 8.42 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMY) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. The firm had revenue of $383.13 million for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. Sell-side analysts anticipate that Hypermarcas will post 0.53 earnings per share for the current year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.